<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ginseng Res</journal-id><journal-title-group><journal-title>Journal of Ginseng Research</journal-title></journal-title-group><issn pub-type="ppub">1226-8453</issn><issn pub-type="epub">2093-4947</issn></journal-meta><article-meta><article-id pub-id-type="pmid">25379002</article-id><article-id pub-id-type="pmc">4213818</article-id><article-id pub-id-type="publisher-id">S1226-8453(14)00061-X</article-id><article-id pub-id-type="doi">10.1016/j.jgr.2014.05.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>An 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Soo-Hyun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Oh</surname><given-names>Mi-Ra</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Eun-Kyung</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Min-Gul</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Ha</surname><given-names>Ki-Chan</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Seung-Kwon</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Young-Gon</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Byung-Hyun</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Dal-Sik</given-names></name><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Chae</surname><given-names>Soo-Wan</given-names></name><email>soowan@jbnu.ac.kr</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff8" ref-type="aff">8</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff2"><label>2</label>Clinical Trial Center, Chonbuk National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff3"><label>3</label>Healthcare Claims and Management Incorporation, 758 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff4"><label>4</label>Central Research Center, Ilhwa Co., Ltd., 25, Angol-ro, 56Beon-gil, Guri, Gyeonggi, Korea</aff><aff id="aff5"><label>5</label>Department of Urology, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff6"><label>6</label>Department of Biochemistry, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff7"><label>7</label>Department of Laboratory Medicine, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><aff id="aff8"><label>8</label>Department of Pharmacology, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, Korea</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>soowan@jbnu.ac.kr</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>23</day><month>5</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>10</month><year>2014</year></pub-date><volume>38</volume><issue>4</issue><fpage>239</fpage><lpage>243</lpage><history><date date-type="received"><day>14</day><month>1</month><year>2014</year></date><date date-type="rev-recd"><day>30</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 The Korean Society of Ginseng. Published by Elsevier B.V. All rights reserved.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder/><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the CC-BY-NC License (http://creativecommons.org/licenses/by-nc/3.0).</license-p></license></permissions><abstract><sec><title>Background</title><p>To investigate the antidiabetic effects of hydrolyzed ginseng extract (HGE) for Korean participants in an 8-wk, randomized, double-blinded, placebo-controlled clinical trial.</p></sec><sec><title>Methods</title><p>Impaired fasting glucose participants [fasting plasma glucose (FPG)&#x000a0;&#x02265;&#x000a0;5.6mM or&#x000a0;&#x0003c;&#x000a0;6.9mM] who had not been diagnosed with any disease and met the inclusion criteria were recruited for this study. The 23 participants were randomly divided into either the HGE (<italic>n</italic>&#x000a0;=&#x000a0;12, 960&#x000a0;mg/d) or placebo (<italic>n</italic>&#x000a0;=&#x000a0;11) group. Outcomes included measurements of efficacy (FPG, postprandial glucose, fasting plasma insulin, postprandial insulin, homeostatic model assessment-insulin resistance, and homeostatic model assessment-&#x003b2;) and safety (adverse events, laboratory tests, electrocardiogram, and vital signs).</p></sec><sec><title>Results</title><p>After 8&#x000a0;wk of HGE supplementation, FPG and postprandial glucose were significantly decreased in the HGE group compared to the placebo group. No clinically significant changes in any safety parameter were observed. Our study revealed that HGE is a potent antidiabetic agent that does not produce noticeable adverse effects.</p></sec><sec><title>Conclusion</title><p>HGE supplementation may be effective for treating impaired fasting glucose individuals.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>clinical trial</kwd><kwd>hydrolyzed ginseng extract</kwd><kwd>impaired fasting glucose</kwd><kwd>oral glucose tolerance test</kwd><kwd><italic>Panax ginseng</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>Introduction</title><p>There is much concern about the dramatic increase in the population of type 2 diabetes patients. Both the recent prevalence rate and the estimated increase in incidence have become public health problems and create a serious burden on society. In order to identify an individual at increased risk of developing type 2 diabetes, the concept of impaired fasting glucose (IFG) has been introduced by the American Diabetes Association <xref rid="bib1" ref-type="bibr">[1]</xref>. Individuals with IFG have fasting plasma glucose levels between 5.6&#x000a0;mmol/L and 6.9&#x000a0;mmol/L <xref rid="bib2" ref-type="bibr">[2]</xref>. In addition to being more likely to develop diabetes in the near future, these people are at greater risk for cardiovascular disease <xref rid="bib3 bib4" ref-type="bibr">[3,4]</xref>. Therefore, effective approaches to control blood glucose levels are urgently needed. Previous large-scale studies have demonstrated that lifestyle intervention is the best way to achieve this goal <xref rid="bib5 bib6 bib7" ref-type="bibr">[5&#x02013;7]</xref>. Pharmacotherapy is also used to manage individuals with IFG. Paradoxically, medications used to control blood glucose often cause metabolic side effects such as weight gain <xref rid="bib8 bib9" ref-type="bibr">[8,9]</xref>. Thus, the development of alternative therapies is of paramount importance, and in this context, herbal extracts are among the most promising source of new treatments for the prevention of diabetes.</p><p>Ginseng (<italic>Panax ginseng</italic> Meyer) has been used as traditional medicine in the treatment of metabolic diseases, cancer, cardiovascular diseases, and other diseases in a number of Asian countries <xref rid="bib10 bib11 bib12" ref-type="bibr">[10&#x02013;12]</xref>. The bioactive constituents of ginseng include various saponins (ginsenosides) and nonsaponins, and the pharmacological activities of ginseng are mainly attributed to ginsenosides <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>. To date, 80 ginsenosides have been identified in ginseng. These ginsenosides are further biotransformed by intestinal bacteria, which increase intestinal absorption and bioactivity and diminish the toxicity of the metabolite compared to its parent compound <xref rid="bib15 bib16" ref-type="bibr">[15,16]</xref>. In this regard, fermentation using microorganisms or treatment with an appropriate enzyme for the production of more effective compounds has been extensively studied.</p><p>In previous studies, pectinase was used for the biotransformation of ginsenosides in ginseng extract, and this process increased the level of bioactive compounds, including compound K (also known as IH-901), resulting in improved pharmacological functions <xref rid="bib17 bib18" ref-type="bibr">[17,18]</xref>. Although the antidiabetic activities of ginseng have been well documented in animal <xref rid="bib19" ref-type="bibr">[19]</xref> and human <xref rid="bib20" ref-type="bibr">[20]</xref> studies, the improved effects of hydrolyzed ginseng on diabetic patients are not clear. Therefore, in this study, we investigated whether hydrolyzed ginseng extract (HGE) could be effective in reducing the risk of type 2 diabetes in individuals with IFG.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Study design</title><p>This study was an 8-wk, randomized, double-blinded, placebo-controlled clinical trial. The randomization scheme was generated by a computerized procedure. Neither the investigators nor the participants knew the randomization code until the trial was completed and database locked. Participants who responded and met the entry criteria during a telephone screening interview were scheduled for a baseline visit. Participants were scheduled for a screening visit, during which the informed consent was reviewed and signed. At 0&#x000a0;wk and 8&#x000a0;wk, a 75-g oral glucose tolerance test (OGTT) was performed after an overnight fast. A catheter was inserted into a vein and blood samples were obtained prior to (0&#x000a0;min) and after (15&#x000a0;min, 30&#x000a0;min, 60&#x000a0;min, 90&#x000a0;min, and 120&#x000a0;min) consuming a 75-g glucose drink. During the 8-wk intervention period, participants were asked to continue their usual diets and to not take any other functional foods or dietary supplements. Participants were also asked to report for the assessment of any adverse events or any changes in lifestyle and eating patterns and to assess pill compliance.</p></sec><sec id="sec2.2"><label>2.2</label><title>Participants</title><p>The study participants were recruited from the Clinical Trial Center for Functional Foods at Chonbuk National University Hospital, Jeonbuk, Republic of Korea during 2009. IFG participants [fasting plasma glucose (FPG)&#x000a0;&#x02265;&#x000a0;5.6mM and&#x000a0;&#x0003c;&#x000a0;6.9mM] who had not been diagnosed with any disease and met the inclusion criteria were recruited for this study. Exclusion criteria for the study were: (1) abnormal lipid profile values; (2) acute/chronic inflammation; (3) treatment with corticosteroids within the past 4&#x000a0;wk; (4) cardiovascular disease, such as arrhythmia, heart failure, myocardial infarction, or a pacemaker; (5) allergic or hypersensitivity to any of the ingredients in the test products; (6) history of a disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease (Crohn's Disease) or gastrointestinal surgery; (7) participation in any other clinical trials within the past 2&#x000a0;mo; (8) renal disease, such as acute/chronic renal failure or nephrotic syndrome; (9) abnormal hepatic function; (10) treatment by hypolipidemic drug therapy within the past 3&#x000a0;mo; (11) treatment by antipsychotic drug therapy within the past 2&#x000a0;mo; (12) a laboratory test, medical, or psychological conditions deemed by the investigators to interfere with successful participation in the study; (13) history of alcohol or substance abuse; or (14) pregnancy or breast feeding. All participants gave written informed consent prior to beginning the study. The protocol was approved by the Functional Foods Institutional Review Board (FFIRB) of Chonbuk National University Hospital (FFIRB number: 2009-02-001). The protocol was registered in <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov" id="intref0015">www.clinicaltrials.gov</ext-link> (NCT01854164).</p></sec><sec id="sec2.3"><label>2.3</label><title>Test supplement</title><p>HGE was obtained from ILHWA Co. Ltd, (Guri, Republic of Korea), as described previously, with slight modifications <xref rid="bib17" ref-type="bibr">[17]</xref>. The HGE contained 7.54&#x000a0;mg/g of Rg1, 1.87&#x000a0;mg/g of Re, 5.42&#x000a0;mg/g of Rb1, 0.29&#x000a0;mg/g of Rc, 0.36&#x000a0;mg/g of Rb2, and 0.70&#x000a0;mg/g of Rd. The compound K content in the HGE was 6.3&#x000a0;mg/g. It was administered as a capsule (480&#x000a0;mg/cap and 960&#x000a0;mg/d) composed of 30% HGE and 70% diluting agent (pumpkin seed oil, refined palm oil, yellow wax, and sorbic acid). The placebo capsules were composed primarily of powdered rice and pumpkin seed oil and were matched with regard to energy content, flavor, appearance, and dosage (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).</p><p>All participants were instructed to take two capsules/d (one capsule each after breakfast and dinner). HGE and placebo capsules were packaged indistinguishably and labeled with the participant's number. Participants were instructed to bring all remaining supplements at each visit and were withdrawn from the study if the supplement consumption was &#x0003e;&#x000a0;70% of the prescribed dose.</p></sec><sec id="sec2.4"><label>2.4</label><title>Outcome measures</title><p>Efficacy assessments included the following: glucose [FPG, plasma glucose during OGTT (postprandial plasma glucose: PPG), glucose incremental area under the curve (iAUC), and glucose maximum concentration (C<sub>max</sub>)], insulin [fasting plasma insulin (FPI), plasma insulin during OGTT (postprandial plasma insulin: PPI), insulin iAUC, and insulin C<sub>max</sub>], homeostatic model assessment (HOMA)&#x02013;insulin resistance (IR), and HOMA-&#x003b2;, glycated albumin, fructosamine, and HbA1c. The glucose and insulin iAUCs during the OGTT were determined by the trapezoidal method.</p><p>Safety assessments included the following: electrocardiogram, hematology, and laboratory tests (white blood cells, red blood cells, hemoglobin, hematocrit, platelet count, total protein, albumin, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, creatinine, etc.), pulse rate, and blood pressure, along with a personal report and were recorded at every visits.</p><p>Blood samples were analyzed on a Hitachi 7600-110 analyzer (Hitachi High-Technologies Corporation, Tokyo, Japan).</p></sec><sec id="sec2.5"><label>2.5</label><title>Statistical analysis</title><p>Statistical analysis was performed using SAS version 9.2 (SAS Institute, Chicago, IL. USA). Data are shown as the mean values and standard deviation. A Chi-square test was performed to determine differences at baseline in frequencies of categorized variables between the groups. The Student paired <italic>t</italic> test was used for continuous measures to assess differences between prior to and after the 8-wk intervention period. A linear mixed-effects model was applied to repeated measures data for each continuous outcome variable and data. Fixed effects included treatment group, treatment visit, and the interaction between treatment group and visit. A <italic>p</italic>-value&#x000a0;&#x0003c;&#x000a0;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Participants</title><p>Among the 100 participants screened, 77 participants were excluded due to laboratory test results consistent with the exclusion criteria. The remaining 23 participants fulfilled the study criteria and were distributed into two groups, HGE (<italic>n&#x000a0;=</italic>&#x000a0;12, 960&#x000a0;mg/day) and placebo (<italic>n&#x000a0;=</italic>&#x000a0;11).</p><p>One participant from the HGE group and two participants from the placebo group withdrew from the study due to personal reasons. Twenty participants (11 in HGE group and 9 in placebo group) were able to finish the study (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>).</p></sec><sec id="sec3.2"><label>3.2</label><title>Participant characteristics</title><p>General characteristics of the participants are shown in <xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>. There were no significant differences in baseline characteristics between the HGE and placebo groups, such as age, sex, weight, height, and FPG.</p></sec><sec id="sec3.3"><label>3.3</label><title>Safety evaluation</title><p>At each of the clinic visits by the study participants, the investigators determined whether there were any adverse events experienced since the previous visit. No moderate or serious adverse events were reported during the 8-wk study period. The evaluation was also expanded to include laboratory tests, electrocardiogram, and vital signs (blood pressure and pulse). The results of the clinical tests were in the normal range, so no participants withdrew because of adverse events.</p></sec><sec id="sec3.4"><label>3.4</label><title>Efficacy evaluation</title><p>Changes in FPG, PPG, glucose iAUC, glucose C<sub>max</sub>, FPI, PPI, insulin iAUC, and insulin C<sub>max</sub> prior to and after the 8-wk intervention period are shown in <xref rid="fig2 fig3" ref-type="fig">Figs.&#x000a0;2, 3</xref>. After the 8-wk intervention, statistically significant differences were found in FPG (<italic>p&#x000a0;=</italic>&#x000a0;0.017) and PPG<sub>60min</sub> (<italic>p&#x000a0;=</italic>&#x000a0;0.01). PPG<sub>30min</sub> (<italic>p&#x000a0;=</italic>&#x000a0;0.059), FPI (<italic>p&#x000a0;=</italic>&#x000a0;0.063), and PPI<sub>60min</sub> (<italic>p&#x000a0;=</italic>&#x000a0;0.077) showed a tendency to improve more than the placebo group, although there were no significant differences between the groups.</p><p>Changes in HOMA&#x02013;IR and HOMA-&#x003b2; prior to and after the 8-wk intervention period are shown in <xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>. After the 8-wk intervention, there were no significant differences between the groups.</p></sec></sec><sec sec-type="discussion" id="sec4"><label>4</label><title>Discussion</title><p>The objective of this study was to determine the effect of HGE supplementation on the glycemic control in patients with IFG individuals and consequently be a possible nutritional approach to reducing the incidence of type 2 diabetes development. Although ginseng has been reported to possess antidiabetic activities in type 2 diabetic animals <xref rid="bib21 bib22" ref-type="bibr">[21,22]</xref> and patients <xref rid="bib23 bib24" ref-type="bibr">[23,24]</xref>, the effect of HGE on&#x000a0;type 2 diabetic patients or high-risk individuals has not been reported. After HGE supplementation, impaired fasting glucose levels returned to near-physiological levels after 8&#x000a0;wk of supplementation.</p><p>In general, deglycosylated ginsenosides are more readily absorbed by the human intestinal tract than their counterparts and have greater pharmacological functions. Nevertheless, these forms of ginsenosides are difficult to obtain because of their lower natural abundance in ginseng extract. Additionally, it is very difficult to synthesize deglycosylated ginsenosides chemically in order to develop them into a therapeutic medicine. In this regard, various attempts, including microbial conversion and enzymatic catalysis, have been made to enrich ginsenosides with less sugar. In this study, we used an enzymatic catalysis method because this approach has substantial advantages such as high selectivity, mild reaction conditions, and environmental compatibility. Pectinase is an enzyme able to degrade pectic substances by hydrolyzing the ester bond between galacturonic acid and methanol or by cleaving the glycosidic bonds of specific polymers <xref rid="bib22" ref-type="bibr">[22]</xref>. Indeed, Jin et&#x000a0;al <xref rid="bib17" ref-type="bibr">[17]</xref> used pectinase to hydrolyze ginsenosides and found that compound K is more readily absorbed from HGE compared to non-HGE in human individuals. Compound K has received increasing attention because various pharmacologic actions including anticancer <xref rid="bib25" ref-type="bibr">[25]</xref>, anti-inflammation <xref rid="bib26" ref-type="bibr">[26]</xref>, and antidiabetes <xref rid="bib27" ref-type="bibr">[27]</xref> were shown to be mediated by this compound. Using pectinase-hydrolyzed ginseng extract, Ramesh et&#x000a0;al <xref rid="bib28" ref-type="bibr">[28]</xref> found an improved antioxidant status and minimized occurrence of oxidative stress-related disorders in aged rats. Moreover, Yuan et&#x000a0;al <xref rid="bib29 bib30" ref-type="bibr">[29,30]</xref> reported that pectinase-processed ginseng radix had antidiabetic and hypolipidemic effects in high fat diet-fed ICR mice. Taken together, pectinase seems to be an effective tool to transform ginsenosides into deglycosylated ginsenosides, thereby enhancing the bioavailability and functionality of ginseng.</p><p>Our data demonstrate that 8&#x000a0;wk of HGE supplementation causes a significant reduction in FPG (<italic>p&#x000a0;=</italic>&#x000a0;0.017) and PPG<sub>60min</sub> (<italic>p&#x000a0;=</italic>&#x000a0;0.01) in IFG individuals. Such reductions may be due to one or a combination of different mechanisms, including intestinal glucose absorption <xref rid="bib31 bib32" ref-type="bibr">[31,32]</xref>, insulin secretion from pancreatic &#x003b2;-cells <xref rid="bib33" ref-type="bibr">[33]</xref>, or peripheral glucose utilization <xref rid="bib34" ref-type="bibr">[34]</xref>. After the supplementation of HGE, noticeable but not significant difference was found in the glucose level at an earlier time point (PPG<sub>30min</sub>, <italic>p&#x000a0;=</italic>&#x000a0;0.059) during OGTT. This result suggests that HGE slows the absorption of glucose in the intestinal lumen. Also, our findings of significant decreases in FPG and PPG<sub>60min</sub> suggest one additional possibility, in which HGE improves glucose intolerance through increasing the insulin action on the target tissues responsible for glucose uptake. Moreover, FPI (<italic>p&#x000a0;=</italic>&#x000a0;0.063) and PPI<sub>60min</sub> (<italic>p&#x000a0;=</italic>&#x000a0;0.077) showed a tendency to improve in the HGE group compared to the placebo group. In supporting this possibility, ginsenosides CK and Rg1 have been reported to enhance insulin-mediated glucose uptake in 3T3-L1 adipocytes, which is related to the increased GLUT4 translocation <xref rid="bib27 bib35" ref-type="bibr">[27,35]</xref>. Similarly, administration of HGE improves glucose homeostasis and insulin resistance state (or glucose and lipid parameters) in high fat diet-fed mice via activation of AMP-dependent protein kinase in muscle tissue <xref rid="bib29 bib30" ref-type="bibr">[29,30]</xref>. In this study, however, there was no significant difference in HOMA-&#x003b2;, suggesting no effect on insulin secretion. In contrast to our results, studies reveal that ginseng significantly stimulates insulin release from pancreatic &#x003b2;-cells <xref rid="bib36 bib37" ref-type="bibr">[36,37]</xref>. These discrepancies could be due to the differences in designs (human studies vs. animal studies) and materials (hydrolyzed ginseng vs. nonhydrolyzed ginseng) used in the studies. Because this was a relatively small-scale and short-term study, further large-scale and long-term studies are needed to fully evaluate the detailed mechanism of HGE.</p><p>We allowed participants to maintain their usual diet and activity without conducting surveys about their lifestyles. Therefore, the participants' diets and activity levels were not accurately controlled. For a more accurate study, the control of lifestyle factors, such as food intake and physical activity, is necessary. Despite this limitation, data from our study suggest that HGE is effective as a glucose-lowering agent. Thus, combined with lifestyle modification, the glucose-lowering effect of hydrolyzed ginseng will become more pronounced.</p></sec><sec id="sec5"><title>Conflicts of interest</title><p>All contributing authors declare no conflicts of interest.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>The Expert Committee on the Diagnosis CoDM</surname></name></person-group><article-title>Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</article-title><source>Diabetes Care</source><volume>20</volume><year>1997</year><fpage>1183</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">9203460</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>American Diabetes Association</surname></name></person-group><article-title>Diagnosis and classification of diabetes mellitus</article-title><source>Diabetes Care</source><volume>37</volume><issue>Suppl.&#x000a0;1</issue><year>2014</year><fpage>S81</fpage><lpage>S90</lpage><pub-id pub-id-type="pmid">24357215</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>E.L.</given-names></name><name><surname>Zimmet</surname><given-names>P.Z.</given-names></name><name><surname>Welborn</surname><given-names>T.A.</given-names></name><name><surname>Jolley</surname><given-names>D.</given-names></name><name><surname>Magliano</surname><given-names>D.J.</given-names></name><name><surname>Dunstan</surname><given-names>D.W.</given-names></name><name><surname>Cameron</surname><given-names>A.J.</given-names></name><name><surname>Dwyer</surname><given-names>T.</given-names></name><name><surname>Taylor</surname><given-names>H.R.</given-names></name><name><surname>Tonkin</surname><given-names>A.M.</given-names></name></person-group><article-title>Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)</article-title><source>Circulation</source><volume>116</volume><year>2007</year><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">17576864</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Meigs</surname><given-names>J.B.</given-names></name><name><surname>Nathan</surname><given-names>D.M.</given-names></name><name><surname>D'Agostino</surname><given-names>R.B.</given-names><suffix>Sr.</suffix></name><name><surname>Wilson</surname><given-names>P.W.</given-names></name><collab>the Framingham Offspring Study</collab></person-group><article-title>Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study</article-title><source>Diabetes Care</source><volume>25</volume><year>2002</year><fpage>1845</fpage><lpage>1850</lpage><pub-id pub-id-type="pmid">12351489</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>W.C.</given-names></name><name><surname>Barrett-Connor</surname><given-names>E.</given-names></name><name><surname>Fowler</surname><given-names>S.E.</given-names></name><name><surname>Hamman</surname><given-names>R.F.</given-names></name><name><surname>Lachin</surname><given-names>J.M.</given-names></name><name><surname>Walker</surname><given-names>E.A.</given-names></name><name><surname>Nathan</surname><given-names>D.M.</given-names></name><collab>Diabetes Prevention Program Research Group</collab></person-group><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>N&#x000a0;Engl J Med</source><volume>346</volume><year>2002</year><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">11832527</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>X.R.</given-names></name><name><surname>Li</surname><given-names>G.W.</given-names></name><name><surname>Hu</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>J.X.</given-names></name><name><surname>Yang</surname><given-names>W.Y.</given-names></name><name><surname>An</surname><given-names>Z.X.</given-names></name><name><surname>Hu</surname><given-names>Z.X.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>J.Z.</given-names></name><name><surname>Cao</surname><given-names>H.B.</given-names></name></person-group><article-title>Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study</article-title><source>Diabetes Care</source><volume>20</volume><year>1997</year><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">9096977</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Tuomilehto</surname><given-names>J.</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>J.</given-names></name><name><surname>Eriksson</surname><given-names>J.G.</given-names></name><name><surname>Valle</surname><given-names>T.T.</given-names></name><name><surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname><given-names>H.</given-names></name><name><surname>Ilanne-Parikka</surname><given-names>P.</given-names></name><name><surname>Kein&#x000e4;nen-Kiukaanniemi</surname><given-names>S.</given-names></name><name><surname>Laakso</surname><given-names>M.</given-names></name><name><surname>Louheranta</surname><given-names>A.</given-names></name><name><surname>Rastas</surname><given-names>M.</given-names></name></person-group><article-title>Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</article-title><source>N&#x000a0;Engl J Med</source><volume>344</volume><year>2001</year><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="pmid">11333990</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Derosa</surname><given-names>G.</given-names></name><name><surname>Maffioli</surname><given-names>P.</given-names></name></person-group><article-title>Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes</article-title><source>Diabetes Res Clin Pract</source><volume>91</volume><year>2011</year><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">20832133</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Mitri</surname><given-names>J.</given-names></name><name><surname>Hamdy</surname><given-names>O.</given-names></name></person-group><article-title>Diabetes medications and body weight</article-title><source>Expert Opin Drug Saf</source><volume>8</volume><year>2009</year><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">19538102</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>P.P.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Shu</surname><given-names>X.O.</given-names></name></person-group><article-title>Ginseng and <italic>Ganoderma lucidum</italic> use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study</article-title><source>PloS One</source><volume>7</volume><year>2012</year><fpage>e39343</fpage><pub-id pub-id-type="pmid">22745737</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Reeds</surname><given-names>D.N.</given-names></name><name><surname>Patterson</surname><given-names>B.W.</given-names></name><name><surname>Okunade</surname><given-names>A.</given-names></name><name><surname>Holloszy</surname><given-names>J.O.</given-names></name><name><surname>Polonsky</surname><given-names>K.S.</given-names></name><name><surname>Klein</surname><given-names>S.</given-names></name></person-group><article-title>Ginseng and ginsenoside Re do not improve &#x003b2;-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes</article-title><source>Diabetes Care</source><volume>34</volume><year>2011</year><fpage>1071</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">21411505</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Hou</surname><given-names>S.Z.</given-names></name><name><surname>Luo</surname><given-names>P.</given-names></name><name><surname>Zeng</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>Wong</surname><given-names>Y.F.</given-names></name><name><surname>Jiang</surname><given-names>Z.H.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group><article-title>Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism</article-title><source>J&#x000a0;Ethnopharmachol</source><volume>135</volume><year>2011</year><fpage>287</fpage><lpage>298</lpage></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Taira</surname><given-names>S.</given-names></name><name><surname>Ikeda</surname><given-names>R.</given-names></name><name><surname>Yokota</surname><given-names>N.</given-names></name><name><surname>Osaka</surname><given-names>I.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Sahashi</surname><given-names>Y.</given-names></name></person-group><article-title>Mass spectrometric imaging of ginsenosides localization in <italic>Panax ginseng</italic> root</article-title><source>Am J Chin Med</source><volume>38</volume><year>2010</year><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">20503467</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.Z.</given-names></name><name><surname>Ni</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.L.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Mehendale</surname><given-names>S.R.</given-names></name><name><surname>Yuan</surname><given-names>C.S.</given-names></name></person-group><article-title>Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA</article-title><source>J&#x000a0;Agr Food Chem</source><volume>57</volume><year>2009</year><fpage>2363</fpage><lpage>2367</lpage><pub-id pub-id-type="pmid">19256509</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>A.</given-names></name><name><surname>Jia</surname><given-names>W.</given-names></name></person-group><article-title>Traditional Chinese medicine: balancing the gut ecosystem</article-title><source>Phytother Res</source><volume>23</volume><year>2009</year><fpage>1332</fpage><lpage>1335</lpage><pub-id pub-id-type="pmid">19253310</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.Y.</given-names></name><name><surname>Qi</surname><given-names>L.W.</given-names></name><name><surname>Wang</surname><given-names>C.Z.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides</article-title><source>Am J Chin Med</source><volume>39</volume><year>2011</year><fpage>1103</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">22083984</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Seo</surname><given-names>J.H.</given-names></name><name><surname>Uhm</surname><given-names>Y.K.</given-names></name><name><surname>Jung</surname><given-names>C.Y.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Yim</surname><given-names>S.V.</given-names></name></person-group><article-title>Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>139</volume><year>2012</year><fpage>664</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">22178175</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Ramesh</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>S.W.</given-names></name><name><surname>Sung</surname><given-names>J.H.</given-names></name><name><surname>Hwang</surname><given-names>S.Y.</given-names></name><name><surname>Sohn</surname><given-names>S.H.</given-names></name><name><surname>Yoo</surname><given-names>S.K.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group><article-title>Effect of fermented <italic>Panax ginseng</italic> extract (GINST) on oxidative stress and antioxidant activities in major organs of aged rats</article-title><source>Exp Gerontol</source><volume>47</volume><year>2012</year><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">22075532</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>Y.N.</given-names></name><name><surname>Sun</surname><given-names>G.Z.</given-names></name><name><surname>Ruan</surname><given-names>C.C.</given-names></name></person-group><article-title>Antidiabetic effects of malonyl ginsenosides from <italic>Panax ginseng</italic> on type 2 diabetic rats induced by high-fat diet and streptozotocin</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>145</volume><year>2013</year><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">23147499</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S.W.</given-names></name><name><surname>Benzie</surname><given-names>I.F.</given-names></name><name><surname>Chu</surname><given-names>T.T.</given-names></name><name><surname>Fok</surname><given-names>B.S.</given-names></name><name><surname>Tomlinson</surname><given-names>B.</given-names></name><name><surname>Critchley</surname><given-names>L.A.</given-names></name></person-group><article-title>Effect of <italic>Panax ginseng</italic> supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial</article-title><source>Diabetes Obes Metab</source><volume>10</volume><year>2008</year><fpage>1125</fpage><lpage>1127</lpage><pub-id pub-id-type="pmid">18355331</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Han</surname><given-names>G.C.</given-names></name><name><surname>Ko</surname><given-names>S.K.</given-names></name><name><surname>Sung</surname><given-names>J.H.</given-names></name><name><surname>Chung</surname><given-names>S.H.</given-names></name></person-group><article-title>Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice</article-title><source>J&#x000a0;Agr Food Chem</source><volume>55</volume><year>2007</year><fpage>10641</fpage><lpage>10648</lpage><pub-id pub-id-type="pmid">18034458</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>W.J.</given-names></name><name><surname>Oh</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>M.S.</given-names></name><name><surname>Ji</surname><given-names>G.E.</given-names></name></person-group><article-title>Anti-hyperglycemic effect of fermented ginseng in type 2 diabetes mellitus mouse model</article-title><source>Phytother Res</source><volume>27</volume><year>2013</year><fpage>166</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">22511336</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Sievenpiper</surname><given-names>J.L.</given-names></name><name><surname>Sung</surname><given-names>M.K.</given-names></name><name><surname>Di Buono</surname><given-names>M.</given-names></name><name><surname>Seung-Lee</surname><given-names>K.</given-names></name><name><surname>Nam</surname><given-names>K.Y.</given-names></name><name><surname>Arnason</surname><given-names>J.T.</given-names></name><name><surname>Leiter</surname><given-names>L.A.</given-names></name><name><surname>Vuksan</surname><given-names>V.</given-names></name></person-group><article-title>Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies</article-title><source>J&#x000a0;Am Coll Nutr</source><volume>25</volume><year>2006</year><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">16582025</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Vuksan</surname><given-names>V.</given-names></name><name><surname>Stavro</surname><given-names>M.P.</given-names></name><name><surname>Sievenpiper</surname><given-names>J.L.</given-names></name><name><surname>Beljan-Zdravkovic</surname><given-names>U.</given-names></name><name><surname>Leiter</surname><given-names>L.A.</given-names></name><name><surname>Josse</surname><given-names>R.G.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name></person-group><article-title>Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes</article-title><source>Diabetes Care</source><volume>23</volume><year>2000</year><fpage>1221</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">10977009</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Ko</surname><given-names>W.G.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Sung</surname><given-names>J.H.</given-names></name><name><surname>Moon</surname><given-names>C.K.</given-names></name><name><surname>Lee</surname><given-names>B.H.</given-names></name></person-group><article-title>Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease</article-title><source>Biochem Pharmacol</source><volume>60</volume><year>2000</year><fpage>677</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">10927026</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>C.</given-names></name></person-group><article-title>Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-&#x003b1;-induced activation of the NF-&#x003ba;B and JNK pathways in human astroglial cells</article-title><source>Neurosci Lett</source><volume>421</volume><year>2007</year><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17548155</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>S.H.</given-names></name><name><surname>Han</surname><given-names>E.J.</given-names></name><name><surname>Sung</surname><given-names>J.H.</given-names></name><name><surname>Chung</surname><given-names>S.H.</given-names></name></person-group><article-title>Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice</article-title><source>Biol Pharm Bull</source><volume>30</volume><year>2007</year><fpage>2196</fpage><lpage>2200</lpage><pub-id pub-id-type="pmid">17978500</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Dichmann</surname><given-names>O.</given-names></name><name><surname>Engel</surname><given-names>U.</given-names></name><name><surname>Jensen</surname><given-names>D.B.</given-names></name><name><surname>Bilde</surname><given-names>T.</given-names></name></person-group><article-title>Juxtatesticular seminoma</article-title><source>Br J Urol</source><volume>66</volume><year>1990</year><fpage>324</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">2207553</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H.D.</given-names></name><name><surname>Kim</surname><given-names>J.T.</given-names></name><name><surname>Chung</surname><given-names>S.H.</given-names></name></person-group><article-title>Pectinase-processed <italic>Ginseng radix</italic> (GINST) ameliorates hyperglycemia and hyperlipidemia in high fat diet-fed ICR mice</article-title><source>Biomol Ther</source><volume>20</volume><year>2012</year><fpage>220</fpage><lpage>225</lpage></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H.D.</given-names></name><name><surname>Quan</surname><given-names>H.Y.</given-names></name><name><surname>Jung</surname><given-names>M.S.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Kim do</surname><given-names>Y.</given-names></name><name><surname>Chung</surname><given-names>S.H.</given-names></name></person-group><article-title>Anti-diabetic effect of pectinase-processed <italic>Ginseng radix</italic> (GINST) in high fat diet-fed ICR mice</article-title><source>J&#x000a0;Ginseng Res</source><volume>35</volume><year>2011</year><fpage>308</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">23717074</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Onomura</surname><given-names>M.</given-names></name><name><surname>Tsukada</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>K.</given-names></name><name><surname>Hosokawa</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name><name><surname>Kodama</surname><given-names>M.</given-names></name><name><surname>Ohya</surname><given-names>M.</given-names></name><name><surname>Seino</surname><given-names>Y.</given-names></name></person-group><article-title>Effects of <italic>Ginseng radix</italic> on sugar absorption in the small intestine</article-title><source>Am J Chin Med</source><volume>27</volume><year>1999</year><fpage>347</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">10592843</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Konno</surname><given-names>C.</given-names></name><name><surname>Furuya</surname><given-names>T.</given-names></name></person-group><article-title>Effects of tissue cultured ginseng on gastric secretion and pepsin activity</article-title><source>Yakugaku Zasshi</source><volume>111</volume><year>1991</year><fpage>770</fpage><lpage>774</lpage><comment>[In Japanese]</comment><pub-id pub-id-type="pmid">1806658</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Waki</surname><given-names>I.</given-names></name><name><surname>Kyo</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>M.</given-names></name><name><surname>Kimura</surname><given-names>M.</given-names></name></person-group><article-title>Effects of a hypoglycemic component of <italic>ginseng radix</italic> on insulin biosynthesis in normal and diabetic animals</article-title><source>J&#x000a0;Pharmacobiodyn</source><volume>5</volume><year>1982</year><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">6759629</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>Y.</given-names></name><name><surname>Takagi</surname><given-names>S.</given-names></name><name><surname>Miura</surname><given-names>T.</given-names></name><name><surname>Usami</surname><given-names>M.</given-names></name><name><surname>Kako</surname><given-names>M.</given-names></name><name><surname>Ishihara</surname><given-names>E.</given-names></name><name><surname>Yano</surname><given-names>H.</given-names></name><name><surname>Tanigawa</surname><given-names>K.</given-names></name><name><surname>Seino</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice</article-title><source>Biol Pharma Bull</source><volume>19</volume><year>1996</year><fpage>1238</fpage><lpage>1240</lpage></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.C.</given-names></name><name><surname>Lin</surname><given-names>C.Y.</given-names></name><name><surname>Huang</surname><given-names>S.F.</given-names></name><name><surname>Lin</surname><given-names>H.C.</given-names></name><name><surname>Chang</surname><given-names>W.L.</given-names></name><name><surname>Chang</surname><given-names>T.C.</given-names></name></person-group><article-title>Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3T3-L1 adipocytes</article-title><source>J&#x000a0;Agr Food Chem</source><volume>58</volume><year>2010</year><fpage>6039</fpage><lpage>6047</lpage><pub-id pub-id-type="pmid">20441170</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name></person-group><article-title>Korean red ginseng stimulates insulin release from isolated rat pancreatic islets</article-title><source>J&#x000a0;Ethnopharmacol</source><volume>120</volume><year>2008</year><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">18773949</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.M.</given-names></name><name><surname>Hong</surname><given-names>S.M.</given-names></name><name><surname>Sung</surname><given-names>S.R.</given-names></name><name><surname>Lee</surname><given-names>J.E.</given-names></name><name><surname>Kwon</surname><given-names>D.Y.</given-names></name></person-group><article-title>Extracts of <italic>Rehmanniae radix, Ginseng radix</italic> and <italic>Scutellariae radix</italic> improve glucose-stimulated insulin secretion and &#x003b2;-cell proliferation through IRS2 induction</article-title><source>Genes Nutr</source><volume>2</volume><year>2008</year><fpage>347</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">18850229</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgments</title><p>This research was supported by a grant from the <funding-source id="gs1">Plant Diversity Research Center of the 21<sup>st</sup> Century Frontier Program, Republic of&#x000a0;Korea</funding-source> (M106KD0110018-09K0401-01810). This study was conducted at the Clinical Trial Center for Functional Foods at Chonbuk National University Hospital.</p></ack><fn-group><fn id="d32e343"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0" id="intref0010">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></fn></fn-group></back><floats-group><fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>CONSORT diagram showing the study flow during the 8-wk intervention.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p>Blood glucose level and incremental area under the curve (iAUC) obtained during the oral glucose tolerance test prior to and after treatment with hydrolyzed ginseng extract or placebo. All values are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation. Derived from generalized linear model adjusted for baseline and <italic>p</italic>-value compared to the placebo group. *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p>Blood insulin level and incremental area under the curve (iAUC) obtained during the oral glucose tolerance test prior to and after treatment with hydrolyzed ginseng extract or placebo. All values are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation. Derived from generalized linear model adjusted for baseline.</p></caption><graphic xlink:href="gr3"/></fig><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>Composition of test products provided/d</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Placebo supplement<hr/></th><th colspan="2">Hydrolyzed ginseng extract supplement<hr/></th></tr><tr><th>Component</th><th>Content (%)</th><th>Component</th><th>Content (%)</th></tr></thead><tbody><tr><td>Powdered rice</td><td align="char">10</td><td>Fermented ginseng extract</td><td align="char">30</td></tr><tr><td>Pumpkin seeds oil</td><td align="char">65.84</td><td>Pumpkin seeds oil</td><td align="char">55.4</td></tr><tr><td>Refined palm oil</td><td align="char">15.44</td><td>Refined palm oil</td><td align="char">9.0</td></tr><tr><td>Yellow wax</td><td align="char">7.72</td><td>Yellow wax</td><td align="char">4.6</td></tr><tr><td>Sorbic acid</td><td align="char">1</td><td>Sorbic acid</td><td align="char">1</td></tr><tr><td>Total</td><td align="char">100</td><td>Total</td><td align="char">100</td></tr></tbody></table></table-wrap><table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>Demographic characteristics of the study participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Placebo group (<italic>n&#x000a0;=</italic>&#x000a0;9)</th><th>HGE group (<italic>n&#x000a0;=</italic>&#x000a0;11)</th><th><italic>p</italic><xref rid="tbl2fn1" ref-type="table-fn">1)</xref></th></tr></thead><tbody><tr><td>Age (y)</td><td>44.56&#x000a0;&#x000b1;&#x000a0;10.48</td><td>50.45&#x000a0;&#x000b1;&#x000a0;12.36</td><td align="char">0.271</td></tr><tr><td>Weight (kg)</td><td>68.00&#x000a0;&#x000b1;&#x000a0;12.75</td><td>67.00&#x000a0;&#x000b1;&#x000a0;11.43</td><td align="char">0.855</td></tr><tr><td>Height (cm)</td><td>165.33&#x000a0;&#x000b1;&#x000a0;7.89</td><td>167.18&#x000a0;&#x000b1;&#x000a0;11.33</td><td align="char">0.684</td></tr><tr><td>Sex (M/F)</td><td>4/5</td><td>6/5</td><td align="char">1.000<xref rid="tbl2fn2" ref-type="table-fn">2)</xref></td></tr><tr><td>FPG (mg/dL)</td><td>105.56&#x000a0;&#x000b1;&#x000a0;6.54</td><td>109.36&#x000a0;&#x000b1;&#x000a0;6.96</td><td align="char">0.227</td></tr><tr><td>FPG (mmol/L)</td><td>5.9&#x000a0;&#x000b1;&#x000a0;0.4</td><td>6.1&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="char">0.227</td></tr></tbody></table><table-wrap-foot><fn><p>All values are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation</p><p>FPG, fasting plasma glucose. HGE, hydrolyzed ginseng extract</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fn1"><label>1)</label><p>Analyzed by independent <italic>t</italic>-test and <italic>p</italic>-value compared to the placebo group</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fn2"><label>2)</label><p>Analyzed by Fisher's exact test</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3" position="float"><label>Table&#x000a0;3</label><caption><p>Homeostatic model assessment (HOMA)&#x02013;insulin resistance (IR) and HOMA-&#x003b2; level obtained prior to and after treatment with hydrolyzed ginseng extract (HGE) or placebo</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="3">Placebo group (<italic>n</italic>&#x000a0;=&#x000a0;9)<hr/></th><th colspan="3">HGE group (<italic>n&#x000a0;=</italic>&#x000a0;11)<hr/></th><th rowspan="2"><italic>p</italic><xref rid="tbl3fn2" ref-type="table-fn">2)</xref></th></tr><tr><th>0 week</th><th>8 week</th><th><italic>p</italic><xref rid="tbl3fn1" ref-type="table-fn">1)</xref></th><th>0 week</th><th>8 week</th><th><italic>p</italic><xref rid="tbl3fn1" ref-type="table-fn">1)</xref></th></tr></thead><tbody><tr><td>HOMA-IR</td><td align="char">1.87&#x000a0;&#x000b1;&#x000a0;0.91</td><td align="char">2.70&#x000a0;&#x000b1;&#x000a0;2.10</td><td align="char">0.173</td><td align="char">2.73&#x000a0;&#x000b1;&#x000a0;2.11</td><td align="char">1.91&#x000a0;&#x000b1;&#x000a0;1.08</td><td align="char">0.193</td><td align="char">0.137</td></tr><tr><td>HOMA-&#x003b2;</td><td align="char">61.16&#x000a0;&#x000b1;&#x000a0;24.45</td><td align="char">74.68&#x000a0;&#x000b1;&#x000a0;48.41</td><td align="char">0.316</td><td align="char">62.60&#x000a0;&#x000b1;&#x000a0;37.15</td><td align="char">57.18&#x000a0;&#x000b1;&#x000a0;36.01</td><td align="char">0.638</td><td align="char">0.282</td></tr></tbody></table><table-wrap-foot><fn><p>All values are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fn1"><label>1)</label><p>Analyzed by paired <italic>t</italic>-test and <italic>p</italic>-value compared to baseline visit</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fn2"><label>2)</label><p>Derived from generalized linear model adjusted for baseline and <italic>p</italic>-value compared to placebo group</p></fn></table-wrap-foot></table-wrap></floats-group></article>